This media surveillance collects articles reported through publicly available web sites.
It is created with the Europe Media Monitor (EMM).
The selection and placement of stories are determined automatically by a computer program.
Headlines
- USA: coronavirus is spreading too rapidly and too broadly for the U.S. to get it under control as some other countries have; the US will not be on EU's travel 'safe list'
- Brazil: Protests target President Bolsonaro after Brazil's worst coronavirus week
- Spain: As EU prepares to reopen borders, Spanish experts stress importance of coronavirus safety measures
- Germany: infection rate holds below key threshold, cases steady
- Ireland reported a ‘worrying’ trend in new cases according to its Chief Medical Officer
- Belgium averages 82 infections and 5 deaths per day
- Luxembourg reported 14 new confirmed cases in Monday update
- Australia: Victoria state announces second lockdown in hotspots
- New Zealand cancelled the 2021 Asia-Pacific Economic Cooperation (APEC) Summit, will lead it virtually
- In South Africa, cases continue to rise at an alarming rate with over 6,000 new daily infections
- India: almost 60,000 cases have been reported over the last three days
- Indonesia: second largest province East Java became Indonesia's epicenter
- South Korea: new cases below 50 for second, but religious gathering-tied infections still on rise
- Japan: Tokyo’s spike continues as capital reports 54 new cases
- China reports 19 new cases including seven in Beijing
The following news were found among the most mentioned/retweeted items:
- "After 500,000 deaths, WHO warns worst of coronavirus pandemic is yet to come" (cbsnews)
- "Gilead’s coronavirus treatment remdesivir to cost $3,120 per U.S. patient with private insurance" (cnbc)
- "This coronavirus mutation has taken over the world. Scientists are trying to understand why." (washingtonpost)
- "California’s slide from coronavirus success to danger zone began Memorial Day" (latimes)
- "COVAXIN, India's First COVID-19 Vaccine Candidate, Set For Phase I, II Human Trials" (ndtv)
- "Flawed COVID-19 antibody tests shipped without FDA review. A 60 Minutes investigation has found that federal officials knew many COVID-19 antibody testing kits had flaws, but allowed them to enter the U.S. market. " (cbsnews)
The most mentioned English sources were the New York Times, the Washington Post, CNN, CBS news and the LA Times.
Clarin, RT (Spanish Version), Infobae, El Pais and El Tiempo, and Le Monde and Le Parisien were among the most mentioned Spanish and French sources, respectively.
Extracted Quotes
Tedros Adhanom Ghebreyesus (WHO, Director-General):
"The hard reality is that this is not even close to being over. Although many countries have made some progress globally, the pandemic is actually speeding up."
Fact Check
Fact checked: health-related claims
- Fact checkers debunk a list of purported treatments for the novel coronavirus, including a daily dose of vitamins, exposure to sunlight and a diet of alkaline foods (afpfactcheck).
- Fact checkers debunk claims that salt-water gargles and steam inhalation kill the coronavirus (fatabyyano).
- Fact checkers debunk claims that the WHO has declared that the coronavirus lives longest on cabbage leaves and it is, therefore, better to not eat cabbage, reporting that the WHO has never made such a statement (cekfakta).
Fact checked: anti-vax narratives
- Fact checkers debunk a social media post claiming that a “whistleblower” from GlaxoSmithKline (GSK), a UK-headquartered multinational pharmaceutical company, said antigens in an upcoming COVID-19 vaccine are “proven to cause infertility in up to 97% of recipients” (aapfactcheck).
- Fact checkers debunk claims that Bill Gates owns the patent and vaccine for coronavirus and is a partner “ in the Lab in Wuhan China”, reporting that there is no patent for the virus that causes COVID-19 and there is not yet an effective vaccine (fullfact).
Download PDF
Contact
Mail to JRC-EMM-SUPPORTec [dot] europa [dot] eu (subject: COVID-19%20media%20surveillance) (JRC-EMM-SUPPORT[at]ec[dot]europa[dot]eu)
Related Content
Details
- Publication date
- 30 June 2020